Hyperthermic Intraperitoneal Chemotherapy
Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma
... Several case studies and a systematic review on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy have been published for pseudomysoma peritonei. Although no randomized ...
5
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study
... plus hyperthermic intraperitoneal chemotherapy (HIPEC) has been devel- oped over the past 3 decades, taking advantages of sur- gery to reduce visible tumor burden, and regional hyperthermic ...
9
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Advanced Ovarian Carcinoma: Initial Experience in Mexico
... Abstract: Background: Ovarian cancer is a lethal tumor, 70% of which occurs in locally advanced stages. Despite its high initial response rate to chemotherapy, recurrence takes place in up to 90%. Prognosis of ...
5
<p>Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles</p>
... of intraperitoneal metastases, is the main cause of ...to hyperthermic intraperitoneal chemotherapy (HIPEC) signi fi cantly improves the prognosis of patients suffering peritoneal gastric ...
6
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
... OR Hyperthermic Intraperitoneal Chemotherapy) OR Chemo- therapy, Hyperthermic Intraperitoneal) OR Hyperthermic Intraperitoneal Chemotherapies) OR intraperitoneal ...
9
Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
... Background: The goal of the study was to investigate the current clinical practices among oncologic surgeons regarding cytoreductive surgery (CRS) with intraoperative hyperthermic intraperitoneal ...
6
Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis
... This study evaluated the potential of selected nanovehicles in modified targeted hyperthermic intraperitoneal chemotherapy without perfusion as a novel chemotherapeutic strategy for peritoneal ...
23
Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high risk gastric cancer patients
... Our study demonstrated the preliminary results of a multimodality treatment protocol that involved the as- sociation of perioperative systemic and intraoperative hyperthermic chemotherapy with radical ...
7
Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
... HIPEC: Hyperthermic intraperitoneal chemotherapy; ICU: Intensive care unit; INR: International normalized ratio; IP: Intraperitoneal; LAMN: Low-grade appendiceal mucinous neoplasm; LOS: Length ...
7
<p>Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations</p>
... systemic chemotherapy have been made, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remain the mainstay of ...
11
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver transplanted patient: a case report
... Background: Diagnostic work-ups in transplanted immunosuppressed patients are a challenge as non-specific findings may be interpreted as transplant-related complications. If the disease in question is rare and slowly ...
5
Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center
... Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment analysis from a single oncological center RESEARCH Open Access Survival[.] ...
9
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
... with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the treatment of choice for resectable peritoneal carcinomatosis (PC) and improved the survival of these ...
9
Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy
... 1. Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias ...
7
Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
... 23. Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, ...
7
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
... and hyperthermic intraperitoneal chemotherapy provide a promising therapeutic option for highly selected patients with peritoneal carcinomatosis arising from different malignancies such as colorectal ...
8
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Electrolyte Disturbances—Implications for Anesthetic Management
... The administration of hyperthermic intraperitoneal chemotherapy (HIPEC) is often associated with significant intraoperative electrolyte changes. We retrospectively examined the pre-HIPEC and ...
5
View of Anaesthetic Management of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A True Challenge To an Anaesthetist | Journal of Current Medical Research and Opinion
... Patients diseased with gynecological malignancies were believed un- treatable with poor survival chances till hyperthermic intraperitoneal chemotherapy after capital cytoreductive surgery came into ...
6
<p>Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience</p>
... systemic chemotherapy has poor access to the peritoneum due to the plasma-peritoneal barrier, intraperitoneal chemotherapy has been proposed and validated as an effective ...5,6 ...
10
Perioperative Management of Patients Undergonig Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
... Abstract Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedure have demonstrated their efficacy in treating patients with diffused peritoneal carcinomatosis. As a counterpart ...
6